Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GOFMAN J. W., JONES H. B., LINDGREN F. T., LYON T. P., ELLIOTT H. A., STRISOWER B. Blood lipids and human atherosclerosis. Circulation. 1950 Aug;2(2):161–178. doi: 10.1161/01.cir.2.2.161. [DOI] [PubMed] [Google Scholar]
- HUMPHREY J. H. The nature of antistreptolysin S in the sera of man and of other species; antistreptolysin titres in normal and diseased states. Br J Exp Pathol. 1949 Aug;30(4):345–351. [PMC free article] [PubMed] [Google Scholar]
- HUMPHREY J. H. The nature of antistreptolysin S in the sera of man and of other species; the lipoprotein properties of antistreptolysin S. Br J Exp Pathol. 1949 Oct;30(5):365–375. [PMC free article] [PubMed] [Google Scholar]
- KELLNER A., CORRELL J. W., LADD A. T. Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents. J Exp Med. 1951 Apr 1;93(4):373–384. doi: 10.1084/jem.93.4.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KELLNER A., CORRELL J. W., LADD A. T. The influence of intravenously administered surface-active agents on the development of experimental atherosclerosis in rabbits. J Exp Med. 1951 Apr 1;93(4):385–398. doi: 10.1084/jem.93.4.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STOLLERMAN G. H., BERNHEIMER A. W. Inhibition of streptolysin S by the serum of patients with rheumatic fever and acute streptococcal pharyngitis. J Clin Invest. 1950 Sep;29(9):1147–1155. doi: 10.1172/JCI102352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STOLLERMAN G. H., BERNHEIMER A. W., MacLEOD C. M. The association of lipoproteins with the inhibition of streptolysin S by serum. J Clin Invest. 1950 Dec;29(12):1636–1645. doi: 10.1172/JCI102408. [DOI] [PMC free article] [PubMed] [Google Scholar]